Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RLX030 in Women With Pre-eclampsia
NCT01566630Phase 2Terminated
- Sponsor
- Novartis
- Start
- May 2013
- Primary completion
- Aug 2014
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 2 trial of serelaxin in preeclampsia, sponsored by Novartis. Started May 2013; status: terminated.
02
Drugs
serelaxin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT01566630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01566630.